Truemeds Secures $85 Million Funding to Expand Footprint and Team

Truemeds, a telehealth platform, has secured $85 million in funding led by Accel and Peak XV Partners. The company plans to triple its national footprint, expand its team, and set up a technology hub in Bengaluru. Truemeds will use the funds to add fulfillment centers and deliver a seamless customer experience. The platform has raised $135 million to date and is valued at over $400 million.

Truemeds, a telehealth platform, has secured $85 million in funding led by Accel and Peak XV Partners. The company plans to triple its national footprint, expand its team, and set up a technology hub in Bengaluru. Truemeds will use the funds to add fulfillment centers and deliver a seamless customer experience. The platform has raised $135 million to date and is valued at over $400 million.

The investment follows Truemeds' strategic focus on generic medicines, which has helped the company differentiate itself in the competitive online pharmacy market. By recommending lower-cost alternatives to consumers for branded medicines, Truemeds has successfully grown its revenue by over 66% year-over-year to ₹5 billion ($57 million) in the last financial year [2].

The new funding will enable Truemeds to further expand its reach, serving more customers and postal codes across India. With a current customer base of 3 million and an average of 500,000 customers each month, the company aims to significantly increase its user base and market share. This growth will be supported by the addition of fulfillment centers, which will enhance the platform's ability to deliver medications efficiently and effectively.

In addition to expanding its physical presence, Truemeds will also invest in its technology infrastructure. The establishment of a technology hub in Bengaluru will allow the company to innovate and improve its digital services, ensuring a seamless and convenient customer experience. This focus on technology will be crucial for Truemeds to maintain its competitive edge in the rapidly evolving telehealth industry.

The funding round underscores the growing interest in the Indian telehealth market, which is expected to reach $5.3 billion by 2025, growing at a CAGR of 34.1% from 2020 to 2025 [3]. Truemeds' strategic approach to generic medicines and its commitment to customer experience have positioned the company as a leader in this market, attracting significant investment from prominent venture capital firms.

References:
[1] https://economictimes.indiatimes.com/industry/cons-products/electronics/very-soon-well-see-the-first-made-in-india-chip-ashwini-vaishnaw/articleshow/123218802.cms
[2] https://techcrunch.com/2025/08/10/truemeds-challenged-how-indians-buy-medicine-and-saw-a-3-6x-jump-in-valuation/
[3] https://www.marketwatch.com/press-release/indian-telehealth-market-size-and-share-2020-2025-2025-04-20